Danaher Corporation (DHR) Stake Lowered by RiverPoint Capital Management LLC
RiverPoint Capital Management LLC lowered its position in Danaher Corporation (NYSE:DHR) by 38.6% during the first quarter, according to its most recent filing with the SEC. The firm owned 6,570 shares of the conglomerate’s stock after selling 4,138 shares during the period. RiverPoint Capital Management LLC’s holdings in Danaher Corporation were worth $562,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in the company. Israel Discount Bank of New York purchased a new position in shares of Danaher Corporation during the first quarter worth $209,000. DE Burlo Group Inc. raised its stake in shares of Danaher Corporation by 17.8% in the first quarter. DE Burlo Group Inc. now owns 131,450 shares of the conglomerate’s stock worth $11,242,000 after buying an additional 19,900 shares during the last quarter. Exane Derivatives bought a new stake in shares of Danaher Corporation during the first quarter worth approximately $838,000. Bronfman E.L. Rothschild L.P. raised its stake in shares of Danaher Corporation by 30.7% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 17,947 shares of the conglomerate’s stock worth $1,535,000 after buying an additional 4,219 shares during the last quarter. Finally, Toronto Dominion Bank raised its stake in shares of Danaher Corporation by 52.5% in the first quarter. Toronto Dominion Bank now owns 177,994 shares of the conglomerate’s stock worth $15,225,000 after buying an additional 61,239 shares during the last quarter. 76.56% of the stock is currently owned by institutional investors.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same period last year, the firm earned $0.90 earnings per share. The business’s quarterly revenue was up 6.3% compared to the same quarter last year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, June 30th were paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend was Wednesday, June 28th. Danaher Corporation’s dividend payout ratio (DPR) is 17.83%.
WARNING: “Danaher Corporation (DHR) Stake Lowered by RiverPoint Capital Management LLC” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.dailypolitical.com/2017/08/07/danaher-corporation-dhr-stake-lowered-by-riverpoint-capital-management-llc.html.
DHR has been the topic of a number of research analyst reports. Zacks Investment Research lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Monday, June 19th. Deutsche Bank AG restated a “buy” rating and set a $97.00 price objective on shares of Danaher Corporation in a report on Wednesday, June 21st. BTIG Research restated a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a report on Sunday, April 23rd. Vetr upgraded shares of Danaher Corporation from a “buy” rating to a “strong-buy” rating and set a $94.18 price objective on the stock in a report on Thursday, April 20th. Finally, Wells Fargo & Company initiated coverage on shares of Danaher Corporation in a report on Thursday, July 13th. They set a “market perform” rating and a $90.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Danaher Corporation presently has an average rating of “Buy” and a consensus target price of $91.76.
In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the transaction, the senior vice president now directly owns 39,020 shares in the company, valued at $3,283,923.20. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock worth $3,206,426 over the last ninety days. Insiders own 12.20% of the company’s stock.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.